Gossamer Bio, Inc. (GOSS)
0.365
+0.04
(+11.11%)
USD |
NASDAQ |
Apr 01, 16:00
0.3649
0.00 (0.00%)
Pre-Market: 08:59
Gossamer Bio Research and Development Expense (TTM) : 174.07M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 109.27M |
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| Artelo Biosciences, Inc. | 5.423M |
| Axsome Therapeutics, Inc. | 182.48M |
| Crinetics Pharmaceuticals, Inc. | 328.17M |